Mariya Kalinova

937 citations
5 papers · 68 indexed · h-index 3
Topics
SARS-CoV-2 and COVID-19 Research (2 papers)Long-Term Effects of COVID-19 (2 papers)COVID-19 and Mental Health (1 paper)
Partner nations
United KingdomAustralia

In The Last Decade

Mariya Kalinova

5 papers receiving 63 citations

Peers

Mariya Kalinova
Comparison fields: 5 of 39
  • Infectious Diseases 39
  • Pulmonary and Respiratory Medicine 24
  • Modeling and Simulation 21
  • Epidemiology 11
  • Neurology 9
Replace Xujuan Hu with:
Xujuan Hu China
Francisco Fanjul Spain
Florian Götzinger Austria
Stephanie Sutjipto Singapore
Lora Martin United States
Giulia Vivaldi United Kingdom
Xiong Xie China
Serenydd Everden United Kingdom
Paola Marchisio Italy
Caroline Eisele United States
Mariya Kalinova relative to Xujuan Hu China Xujuan Hu's profile →
Citations per field
00.5×3.1×
Xujuan Hu · 1×
Citations per year

Countries citing papers authored by Mariya Kalinova

Since Specialization
Citations

This map shows the geographic impact of Mariya Kalinova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariya Kalinova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariya Kalinova more than expected).

Fields of papers citing papers by Mariya Kalinova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariya Kalinova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariya Kalinova. The network helps show where Mariya Kalinova may publish in the future.

Co-authorship network of co-authors of Mariya Kalinova

This figure shows the co-authorship network connecting the top 25 collaborators of Mariya Kalinova. A scholar is included among the top collaborators of Mariya Kalinova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariya Kalinova. Mariya Kalinova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 9
2 21
3 35
4 2
5 1

About Mariya Kalinova

Mariya Kalinova is a scholar working on Critical Care and Intensive Care Medicine, Neurology and Infectious Diseases, having authored 5 papers that have together received 68 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Long-Term Effects of COVID-19 (2 papers) and COVID-19 and Mental Health (1 paper). The work is most often cited by research in Modeling and Simulation (21 citations), Infectious Diseases (39 citations) and Pulmonary and Respiratory Medicine (24 citations). Mariya Kalinova has collaborated with scholars based in United Kingdom and Australia. Frequent co-authors include Alex Mann, Christopher Chiu, Ben Killingley, Andrew Catchpole, Neil M. Ferguson, Ksenia Sukhova, Anika Singanayagam, Michael R. Barer, Niluka Goonawardane and William Barclay. Their work appears in journals such as Science Immunology, EClinicalMedicine and The Lancet Microbe.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026